In this episode, we’re joined by Janna Manjelievskaia, director of health economics and outcomes research at Veradigm. We discuss Veradigm’s recent Women’s Health Insights Report, which highlights the complicated history around Hormone Replacement Therapy (HRT), a medication used to treat menopause.
The FDA will remove black box warnings on hormone replacement therapies after evidence showed the risks were overstated.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
The HRT Club provides access to a network of over 700 healthcare providers who can prescribe hormone replacement therapies.
For the thousands of adults and children with growth hormone deficiencies, daily injections of replacement hormones are their best bet for preventing the cardiovascular, muscular and metabolic abnormalities associated with the condition. But a few companies are on the hunt for ways to make those injections last longer so that they would require less frequent […]